Keyphrases
Thalassemia
100%
Chelation
100%
Patient Report
18%
Quality of Life
9%
Blood Disorders
9%
Depressive Symptoms
9%
Anxiety Symptoms
9%
Tolerability
9%
Iron Levels
9%
North America
9%
Clinical Trials Network
9%
Non-associated
9%
Combined Modality Therapy
9%
Transfusion
9%
Low Adherence
9%
Longitudinal Cohort
9%
Soma
9%
Ferritin
9%
Self-reported Adherence
9%
Chronic Transfusion
9%
Iron-bearing Burden
9%
Patient Views
9%
Deferoxamine
9%
Iron Chelation Therapy
9%
Body Iron
9%
Beliefs in Medicine
9%
North London
9%
Subcutaneous Infusion
9%
Medicine and Dentistry
Thalassemia
100%
Side Effect
33%
Medicine
33%
Diseases
16%
Drug Therapy
16%
Carisoprodol
16%
Ferritin
16%
Blood Transfusion
16%
Subcutaneous Injection
16%
Sulfhemoglobinemia
16%
Chelation Therapy
16%
Clinical Research
16%
Quality of Life
16%
Deferoxamine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Thalassemia
100%
Side Effect
33%
Tolerability
16%
Clinical Research
16%
Chelation Therapy
16%
Carisoprodol
16%
Hematologic Disease
16%
Ferritin
16%
Deferoxamine
16%
Disease
16%
Subcutaneous Injection
16%